Serina Therapeutics
SER • AMEX
Serina Therapeutics is a publicly traded company trading on AMEX, led by CEO Steven A. Ledger, with a market cap of $28.0M.
CEOSteven A. Ledger
Market Cap$28.0M
Websiteserinatherapeutics.com
Next Earnings
Upcoming earnings announcement for Serina Therapeutics
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (6:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.44
Earnings History
Past 8 earnings reports for Serina Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Q4 2025 | -$0.31Est: -$0.47 | +34.0% | - | — |  10-K/A |
| Nov 13, 2025 | Q3 2025 | -$0.45Est: -$0.51 | +11.8% | - | — | 10-Q |
| Aug 11, 2025 | Q2 2025 | -$0.66Est: -$0.40 | -65.0% | $130.0K | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.49 | — | - | — | 10-Q |
| Mar 24, 2025 | Q4 2024 | -$0.24 | — | -$14.0K | — | 10-K |
| Nov 12, 2024 | Q3 2024 | $0.13 | — | $14.0K | — | 10-Q |
| Aug 9, 2024 | Q2 2024 | $0.51 | — | $51.0K | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$3.38 | — | $5.0K | — | 10-Q |